BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35471740)

  • 1. Liquid-based thin-prep cytology study of lacrimal drainage system in primary acquired nasolacrimal duct obstruction.
    Jang JK; Choi SE; Lew H
    Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):3053-3059. PubMed ID: 35471740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcanalicular endoscopic dacryoplasty in patients with primary acquired nasolacrimal duct obstruction.
    Lee SM; Lew H
    Graefes Arch Clin Exp Ophthalmol; 2021 Jan; 259(1):173-180. PubMed ID: 32743774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and cytological changes in mucinous obstruction diagnosed by dacryoendoscopy.
    Kim D; Lew H
    Sci Rep; 2024 Apr; 14(1):8891. PubMed ID: 38632478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The technique and its role of dacryoendoscopy in the management of the false passage of the lacrimal drainage system.
    Kim M; Lew H
    Sci Rep; 2022 Dec; 12(1):22493. PubMed ID: 36577895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dacryoendoscopic Findings in the Failed Silicone Tube Intubations without Dacryoendoscopy.
    Kim DA; Lew H
    Korean J Ophthalmol; 2022 Dec; 36(6):486-492. PubMed ID: 36220637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing clinical outcomes for endoscopic lacrimal duct recanalization in patients with complete PANDO.
    Javate RM
    Int Ophthalmol; 2023 Jan; 43(1):175-184. PubMed ID: 35809164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcanalicular endoscopic primary dacryoplasty for congenital nasolacrimal duct obstruction.
    Matsumura N; Suzuki T; Goto S; Fujita T; Yamane S; Maruyama-Inoue M; Kadonosono K
    Eye (Lond); 2019 Jun; 33(6):1008-1013. PubMed ID: 30783256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of primary acquired nasolacrimal duct obstruction: Comparison of CT-DCG and dacryoendoscopy in accurately localizing the lacrimal drainage obstructions.
    Zhang W; Li L; Zhang L; Ding Y; Liu X; Ali MJ; Xiao C
    Eur J Ophthalmol; 2024 Feb; ():11206721241230581. PubMed ID: 38327083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Efficacy of Dacryoendoscopy-guided Recanalization and Silicone Tube Intubation.
    Kim SE; Beak JU; Paik JS; Park J; Yang SW
    Korean J Ophthalmol; 2022 Jun; 36(3):185-193. PubMed ID: 35067021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of digital subtraction dacryocystography and dacryoendoscopy in patients with epiphora.
    Bae SH; Park J; Lee JK
    Eye (Lond); 2021 Mar; 35(3):877-882. PubMed ID: 32467631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mucins in human lacrimal sac and nasolacrimal duct.
    Paulsen FP; Corfield AP; Hinz M; Hoffmann W; Schaudig U; Thale AB; Berry M
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):1807-13. PubMed ID: 12714609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
    Yartsev VD; Atkova EL; Ekaterinchev MA
    Int Ophthalmol; 2023 Sep; 43(9):3385-3390. PubMed ID: 37199817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial on silicone intubation in endoscopic mechanical dacryocystorhinostomy (SEND) for primary nasolacrimal duct obstruction.
    Chong KK; Lai FH; Ho M; Luk A; Wong BW; Young A
    Ophthalmology; 2013 Oct; 120(10):2139-45. PubMed ID: 23672972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcanalicular laser dacryocystorhinostomy for acquired nasolacrimal duct obstruction: an audit of 104 patients.
    Mor JM; Matthaei M; Schrumpf H; Koch KR; Bölke E; Heindl LM
    Eur J Med Res; 2018 Nov; 23(1):58. PubMed ID: 30446006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary study on CT retrograde intubation dacryosystography (CT-RIDC) and its impact factors].
    Wang T; Tao H; Han C; Wang P; Bai F; Zhang J
    Zhonghua Yan Ke Za Zhi; 2014 Oct; 50(10):766-71. PubMed ID: 25547580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.
    Lee-Wing MW; Ashenhurst ME
    Ophthalmology; 2001 Nov; 108(11):2038-40. PubMed ID: 11713075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dacryoendoscopic Findings of Patients with Lacrimal Drainage Obstruction Associated with Cancer Treatment.
    Kim Y; Lew H
    Korean J Ophthalmol; 2022 Dec; 36(6):509-517. PubMed ID: 36220641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors influencing the long-term success of lacrimal duct surgery and the prognostic value of dacryocystography].
    Stupp T; Spaniol K; Prokosch V; Thanos S; Pavlidis M
    Klin Monbl Augenheilkd; 2010 Jan; 227(1):43-6. PubMed ID: 20091449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
    Yuksel N; Mutlu M; Kilicarslan A; Akcay E
    Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
    Ali MJ
    Prog Retin Eye Res; 2023 Sep; 96():101193. PubMed ID: 37394093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.